Treatment of Hypertension in Patients 80 Years of Age or Older

In this study, patients 80 years of age or older with sustained systolic hypertension were randomly assigned to receive either the diuretic indapamide, with or without the angiotensin-converting–enzyme inhibitor perindopril, or matching placebos, for a target blood pressure of 150/80 mm Hg. Active t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2008-05, Vol.358 (18), p.1887-1898
Hauptverfasser:	Beckett, Nigel S, Peters, Ruth, Fletcher, Astrid E, Staessen, Jan A, Liu, Lisheng, Dumitrascu, Dan, Stoyanovsky, Vassil, Antikainen, Riitta L, Nikitin, Yuri, Anderson, Craig, Belhani, Alli, Forette, Françoise, Rajkumar, Chakravarthi, Thijs, Lutgarde, Banya, Winston, Bulpitt, Christopher J
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Aged, 80 and over Angiotensin-Converting Enzyme Inhibitors - adverse effects Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive Agents - adverse effects Antihypertensive Agents - therapeutic use Blood Pressure - drug effects Cardiovascular Diseases - epidemiology Cardiovascular Diseases - prevention & control Clinical trials Diuretics - adverse effects Diuretics - therapeutic use Double-Blind Method Drug therapy Drug Therapy, Combination Female Follow-Up Studies Humans Hypertension Hypertension - drug therapy Hypertension - mortality Indapamide - adverse effects Indapamide - therapeutic use Kaplan-Meier Estimate Male Older people Perindopril - adverse effects Perindopril - therapeutic use Stroke - mortality Stroke - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!